Sat, Aug 30, 2014, 8:17 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Array BioPharma, Inc. Message Board

  • cl969cl cl969cl Nov 18, 2013 9:43 AM Flag

    Burnaka, new opinion from Mkt Edge

    Opinion NEUTRAL FROM AVOID Date Opinion Formed 11/18/2013 Price Opinion Formed 5.68
    Score 2 C-Rate 0.0 UPGRADED
    Recommendation
    Stock shows Mildly Improving Conditions. SCORE = 2
    If you are short this stock, hold position. Do not initiate new short sale.
    Stock is Not a Buy Candidate.
    Comment
    Moving Average Convergence/Divergence (MACD) indicates a Bearish Trend.
    Chart pattern indicates a Weak Downward Trend.
    Relative Strength is Bearish.
    Up/Down volume pattern indicates that the stock is under Accumulation.
    The 50 day Moving Average is rising which is Bullish.
    The 200 day Moving Average is rising which is Bullish.
    Price is under Support of 5.84 which is Bearish.
    Watch for resistance at 6.34

    C L

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • burnaka@sbcglobal.net burnaka Nov 18, 2013 7:21 PM Flag

      Thanks for the INFO CL.

      I am planning on being here for roughly two years. I see the one year chart as similar to opk a year or so ago. Slow steady accumulation going on here. Short term the chart does not know Arry will be presenting at Jefferies on Nov 20th, and Piper Jaffray on Dec 3, or about the two presentations at ASH on Dec 9th. Yes 6.34 might be the short term ceiling, for sure, the chart also says if Arry can get over 6.39, scale 6.67, it can test 7.10 and resume the slow climb. If Arry exits 2014 in the 7-8 range that is a solid year, 40% move from 5.00. Of course a buy out in the 20 dollar range would be better but I see that as a couple years off.

 
ARRY
3.95+0.08(+2.07%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.